<SEC-DOCUMENT>0001654954-20-013396-index.html : 20201210
<SEC-HEADER>0001654954-20-013396.hdr.sgml : 20201210
<ACCEPTANCE-DATETIME>20201210164845
ACCESSION NUMBER:		0001654954-20-013396
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20201210
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20201210
DATE AS OF CHANGE:		20201210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOSCIENCE, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38247
		FILM NUMBER:		201381164

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aytu_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: aytu_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>aytu_ex231.htm
<DESCRIPTION>CONSENT OF RSM US LLP
<TEXT>
Document 2 - file: aytu_ex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>aytu_ex991.htm
<DESCRIPTION>AUDITED FINANCIAL STATEMENTS OF NEOS THERAPEUTICS, INC. AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2019 AND DECEMBER 31, 2018
<TEXT>
Document 3 - file: aytu_ex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>aytu_ex992.htm
<DESCRIPTION>UNAUDITED FINANCIAL STATEMENTS OF NEOS THERAPEUTICS, INC. AS OF AND FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2020, AND SEPTEMBER 30, 2019
<TEXT>
Document 4 - file: aytu_ex992.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>aytu_ex993.htm
<DESCRIPTION>UNAUDITED FINANCIAL STATEMENTS OF NEOS THERAPEUTICS, INC. AS OF AND FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2020 AND JUNE 30, 2019
<TEXT>
Document 5 - file: aytu_ex993.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>6
<FILENAME>aytu_ex994.htm
<DESCRIPTION>UNAUDITED FINANCIAL STATEMENTS OF NEOS THERAPEUTICS, INC. AS OF AND FOR THE THREE MONTHS ENDED MARCH 31, 2020, AND MARCH 31, 2019
<TEXT>
Document 6 - file: aytu_ex994.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>7
<FILENAME>aytu_ex995.htm
<DESCRIPTION>UNAUDITED PRO FORMA
<TEXT>
Document 7 - file: aytu_ex995.htm

</DOCUMENT>
</SEC-DOCUMENT>